Sosei Group (4565 JP): 1H FY12/26 flash update
Revenue increased to JPY18.9bn (+25.3% YoY), driven by milestone achievements and strong sales of Pivlaz® and Quviviq®. R&D expenses decreased...
115 Views
Sosei Group (4565 JP): Q1 FY12/26 flash update
Revenue increased to JPY11.3bn (+69.4% YoY), driven by milestone achievements, while R&D expenses decreased by 20.5% YoY. Core operating...
157 Views
Sosei Group (4565 JP): Q3 FY12/25 flash update
Revenue decreased by JPY135mn to JPY21.8bn due to smaller milestone payments, partially offset by Quviviq sales. R&D expenses rose 31.5% YoY...
497 Views
Sosei Group (4565 JP): Q1 FY12/25 flash update
Revenue increased 44.1% YoY to JPY6.6bn, driven by Quviviq® revenue and milestone payments in Q1 FY12/25. R&D expenses rose 20.4% YoY to...
283 Views